Michael J. Tokich - May 15, 2024 Form 4 Insider Report for STERIS plc (STE)

Signature
/s/ Ronald E. Snyder, Authorized Representative under Power of Attorney
Stock symbol
STE
Transactions as of
May 15, 2024
Transactions value $
-$5,066,126
Form type
4
Date filed
5/17/2024, 04:31 PM
Previous filing
Jun 2, 2023
Next filing
Jun 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STE Ordinary Shares Options Exercise $2.47M +32K +75.36% $77.07 74.5K May 15, 2024 Direct
transaction STE Ordinary Shares Sale -$1.18M -5.04K -6.77% $233.34 69.4K May 15, 2024 Direct F1
transaction STE Ordinary Shares Sale -$770K -3.28K -4.73% $234.54 66.1K May 15, 2024 Direct F2
transaction STE Ordinary Shares Sale -$4.13M -17.5K -26.46% $235.84 48.6K May 15, 2024 Direct F3
transaction STE Ordinary Shares Sale -$1.46M -6.18K -12.7% $236.22 42.5K May 15, 2024 Direct F4, F5
holding STE Ordinary Shares 3.56K May 15, 2024 See Footnote Below F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STE Employee Stock Option (right to buy) Options Exercise $0 -32K -100% $0.00* 0 May 15, 2024 Ordinary Shares 32K $77.07 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Price reflects a weighted average sale price for multiple transactions ranging from $233.02 to $233.97 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2 Price reflects a weighted average sale price for multiple transactions ranging from $234.0450 to $234.9550 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3 Price reflects a weighted average sale price for multiple transactions ranging from $235.07 to $236.06 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F4 Price reflects a weighted average sale price for multiple transactions ranging from $236.08 to $236.45 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F5 As of May 15, 2024, 11,455 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,293 on May 31, 2024; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 1,128 on June 3, 2024; 432 on October 1, 2024; 1,293 on June 2, 2025; 573 on June 2, 2025; 564 on June 2, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026 and 564 on June 2, 2026.
F6 Units representing 3,557 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of May 16, 2024.
F7 This option to purchase 32,000 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 32,000 ordinary shares for $77.07 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.